Efficacy and safety of fexapotide triflutate in outpatient medical treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia

Míreanna comhchosúla

• Fexapotide Triflutate Induces Selective Prostate Glandular Pharmaco-Ablation in the Rat
  de réir: Averback P, et al.
  Foilsithe / Cruthaithe: (2019-12-01)
• Fexapotide triflutate vs oral pharmacotherapy as initial therapy for moderate-to-severe benign prostate hyperplasia patients: a cost-effectiveness analysis
  de réir: Yifan Wei, et al.
  Foilsithe / Cruthaithe: (2022-05-01)
• Association of Exercise with Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms
  de réir: Yoo-Hyun Lee, et al.
  Foilsithe / Cruthaithe: (2019-02-01)
• The Urinary Tract Microbiome in Male Genitourinary Diseases: Focusing on Benign Prostate Hyperplasia and Lower Urinary Tract Symptoms
  de réir: Myung Soo Kim, et al.
  Foilsithe / Cruthaithe: (2021-03-01)
• The Potential Role of Urinary Microbiome in Benign Prostate Hyperplasia/Lower Urinary Tract Symptoms
  de réir: Seong Hyeon Yu, et al.
  Foilsithe / Cruthaithe: (2022-08-01)